{"id":"https://openalex.org/W3124550366","doi":"https://doi.org/10.1093/jpp/rgaa050","title":"The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells","display_name":"The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3124550366","doi":"https://doi.org/10.1093/jpp/rgaa050","mag":"3124550366","pmid":"https://pubmed.ncbi.nlm.nih.gov/33791808"},"language":"en","primary_location":{"id":"doi:10.1093/jpp/rgaa050","doi":"https://doi.org/10.1093/jpp/rgaa050","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jpp/rgaa050","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073777364","display_name":"Benchamart Moolmuang","orcid":"https://orcid.org/0000-0003-2008-4021","observed_orcids":["https://orcid.org/0000-0003-2008-4021"]},"institutions":[{"id":"https://openalex.org/I39737112","display_name":"Chulabhorn Research Institute","ror":"https://ror.org/00nb6mq69","country_code":"TH","type":"facility","lineage":["https://openalex.org/I39737112"]}],"countries":["TH"],"is_corresponding":true,"raw_author_name":"Benchamart Moolmuang","raw_affiliation_strings":["Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute , Bangkok,","Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand"],"raw_orcid":"https://orcid.org/0000-0003-2008-4021","affiliations":[{"raw_affiliation_string":"Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute , Bangkok,","institution_ids":["https://openalex.org/I39737112"]},{"raw_affiliation_string":"Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand","institution_ids":["https://openalex.org/I39737112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033575943","display_name":"Mathuros Ruchirawat","orcid":"https://orcid.org/0000-0001-6402-2442","observed_orcids":["https://orcid.org/0000-0001-6402-2442"]},"institutions":[{"id":"https://openalex.org/I39737112","display_name":"Chulabhorn Research Institute","ror":"https://ror.org/00nb6mq69","country_code":"TH","type":"facility","lineage":["https://openalex.org/I39737112"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Mathuros Ruchirawat","raw_affiliation_strings":["Laboratory of Environmental Toxicology, Chulabhorn Research Institute , Bangkok,","Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Environmental Toxicology, Chulabhorn Research Institute , Bangkok,","institution_ids":["https://openalex.org/I39737112"]},{"raw_affiliation_string":"Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand","institution_ids":["https://openalex.org/I39737112"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5073777364"],"corresponding_institution_ids":["https://openalex.org/I39737112"],"apc_list":{"value":2500,"currency":"GBP","value_usd":3400},"apc_paid":null,"fwci":0.6835,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.64337759,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"73","issue":"1","first_page":"40","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.02419999986886978,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.9010000228881836},{"id":"https://openalex.org/keywords/ataxia-telangiectasia-mutated","display_name":"ATM kinase","score":0.7360000014305115},{"id":"https://openalex.org/keywords/atr-kinase","display_name":"ATR kinase","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ku55933","display_name":"KU55933","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ve-821","display_name":"VE-821","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dna-damaging-agents","display_name":"DNA-damaging agents","score":0.7960000038146973},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.8149999976158142},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.46399998664855957},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.5299999713897705},{"id":"https://openalex.org/keywords/chk2","display_name":"Chk2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/p53-deficient-cells","display_name":"p53-deficient cells","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.6439999938011169},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8289999961853027}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6399593353271484},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.6050845980644226},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6007297039031982},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.564581036567688},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5578855276107788},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5450766682624817},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4871101379394531},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4634966552257538},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.45397424697875977},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.4396449029445648},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4136316776275635},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41103309392929077},{"id":"https://openalex.org/C2779486608","wikidata":"https://www.wikidata.org/wiki/Q387082","display_name":"Ataxia-telangiectasia","level":4,"score":0.4103999435901642},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3883640766143799},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3672618567943573},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.30698883533477783},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25582197308540344},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14044982194900513},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0654292106628418},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001260","descriptor_name":"Ataxia Telangiectasia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011753","descriptor_name":"Pyrones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064007","descriptor_name":"Ataxia Telangiectasia Mutated Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/jpp/rgaa050","doi":"https://doi.org/10.1093/jpp/rgaa050","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jpp/rgaa050","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:33791808","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33791808","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324807","display_name":"Chulabhorn Research Institute","ror":"https://ror.org/00nb6mq69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W182201473","https://openalex.org/W1534102370","https://openalex.org/W1542825229","https://openalex.org/W1553367038","https://openalex.org/W1869447257","https://openalex.org/W1936076194","https://openalex.org/W1967630574","https://openalex.org/W1969310368","https://openalex.org/W1976385056","https://openalex.org/W1989475021","https://openalex.org/W1992797151","https://openalex.org/W2012369608","https://openalex.org/W2013895149","https://openalex.org/W2014588353","https://openalex.org/W2022529631","https://openalex.org/W2025769688","https://openalex.org/W2029767217","https://openalex.org/W2040860750","https://openalex.org/W2043972688","https://openalex.org/W2049626897","https://openalex.org/W2054060734","https://openalex.org/W2061197983","https://openalex.org/W2074429674","https://openalex.org/W2075927156","https://openalex.org/W2082446796","https://openalex.org/W2101988823","https://openalex.org/W2105663975","https://openalex.org/W2107894073","https://openalex.org/W2111772438","https://openalex.org/W2128016549","https://openalex.org/W2131833681","https://openalex.org/W2134158374","https://openalex.org/W2136797122","https://openalex.org/W2140990686","https://openalex.org/W2141078344","https://openalex.org/W2154041044","https://openalex.org/W2154141161","https://openalex.org/W2155640249","https://openalex.org/W2159099751","https://openalex.org/W2580220347","https://openalex.org/W2609630616","https://openalex.org/W2616779595","https://openalex.org/W2802959410","https://openalex.org/W4212962560","https://openalex.org/W6737080320"],"related_works":["https://openalex.org/W2154828365","https://openalex.org/W2098457059","https://openalex.org/W4411322791","https://openalex.org/W4362543547","https://openalex.org/W2033665356","https://openalex.org/W4366463919","https://openalex.org/W2766300480","https://openalex.org/W2101988823","https://openalex.org/W2612040991","https://openalex.org/W2114021402"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"whether":[3],"the":[4,28,89,133,167,187],"inhibitions":[5],"of":[6,31,51,73,91,100,116,132,141,169,182,190],"ataxia-telangiectasia":[7],"mutated":[8],"(ATM)":[9],"and":[10,12,21,38,43,59,64,93,103,144,163,174,184,201],"ATM-":[11],"Rad3-related":[13],"(ATR)":[14],"kinases":[15],"by":[16,68,79,107],"their":[17],"specific":[18],"inhibitors,":[19],"KU-55933":[20,63,92,143],"VE-821,":[22,65],"respectively,":[23],"are":[24],"able":[25],"to":[26,87],"promote":[27],"cytotoxic":[29,114,152,188],"activity":[30,153],"genotoxic":[32],"agents":[33,119,149,193],"including":[34],"gemcitabine,":[35],"5-Fluorouracil,":[36],"cisplatin":[37],"doxorubicin,":[39],"in":[40,60,136,157,177,194],"cholangiocarcinoma":[41],"(CCA)":[42],"immortalized":[44],"cholangiocyte":[45],"cell":[46,74,96,123,134,160,203],"lines.":[47,124,161,204],"METHODS:":[48],"Cell":[49],"viability":[50],"cells":[52],"treated":[53],"with":[54,62,146],"DNA":[55,117,126,147,170,191],"damaging":[56,118,127,148,171,192],"agents,":[57],"alone":[58],"combination":[61],"was":[66,85],"determined":[67],"MTT":[69],"assay.":[70],"The":[71,98,113,139],"changes":[72],"cycle":[75,135],"distribution":[76],"were":[77,105],"evaluated":[78],"flow":[80],"cytometry":[81],"analysis.":[82,110],"Colony":[83],"formation":[84],"conducted":[86],"assess":[88],"effects":[90,115,168,189],"VE-821":[94,145],"on":[95],"proliferation.":[97],"levels":[99],"protein":[101],"expression":[102],"phosphorylation":[104],"examined":[106],"western":[108],"blot":[109],"KEY":[111],"FINDINGS:":[112],"varied":[120],"among":[121],"CCA":[122,137,159,178,195],"Each":[125],"drug":[128],"induced":[129],"different":[130],"phases":[131],"cells.":[138,179],"combinations":[140],"both":[142],"promoted":[150],"more":[151],"than":[154],"single":[155],"inhibition":[156],"some":[158],"ATM":[162,183],"ATR":[164,185],"inhibitors":[165],"decreased":[166],"agent-induced":[172],"ATM-Chk2":[173],"ATR-Chk1":[175],"activations":[176],"CONCLUSIONS:":[180],"Inhibitions":[181],"potentiated":[186],"cells,":[196],"especially":[197],"p53":[198],"defective":[199],"HuCCA1":[200],"RMCC1":[202]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-02-01T00:00:00"}